Dremenia VitalOxy Soft
€0.00
Experience the freedom and efficiency of mobile hyperbaric oxygen therapy.
The Dremenia VitalOxy Soft is our lightest pressure chamber and was specifically developed for mobile use . The housing is made of TPU (thermoplastic urethane) – a high-tech material from aerospace that impresses with its robustness and flexibility.
Characteristics
Highly integrated design : intelligent construction, luxurious and comfortable
Large viewing windows : 7 transparent windows prevent claustrophobia and create a bright, open environment
Comfortable access : curved YKK zipper (Japan) makes opening and entry easier
Extremely lightweight : only 13 kg , perfect for travel and mobile use
PSA molecular sieve technology : Ensures continuous oxygen production
Easy to use : Can also be used alone without any problems
The Dremenia VitalOxy Soft is the ideal choice for users looking for a flexible, mobile and effective HBOT solution .
Perfect for use at home or on the go
High mobility and easy operation
Suitable for private users as well as commercial providers
With the VitalOxy Soft you can experience the benefits of hyperbaric oxygen therapy anytime and anywhere – whether for health, regeneration or performance improvement .
Technical data
| feature | specification |
|---|---|
| Model | VitalOxy Soft 80 / 90 |
| oxygen concentration | ≥ 90% (adjustable) |
| Working pressure | 1.2 – 1.5 ATA (adjustable) |
| material | Medical TPU |
| Size | 800×2320mm / 900×2320mm |
| Weight | 13 kg |
| zipper | Japanese YKK zippers, double-guided |
| Pressurization/decompression | 5 – 10 minutes |
| manometer | Internal, for pressure monitoring |
| emergency valve | For accelerated decompression in an emergency |
| metal frame | Keeps shape when emptying |
| Accesories | Cotton protective cover, easy to clean |
| Air release valves | 2 pieces |
| Oxygen supply | 93% under pressure from mask |
Dremenia – milde Überdruckkammern sind kein Medizinprodukt im Sinne der Verordnung (EU) 2017/745 des Europäischen Parlaments und des Rates vom 5. April 2017 über Medizinprodukte, zur Änderung der Richtlinie 2001/83/EG, der Verordnung (EG) Nr. 178/2002 und der Verordnung (EG) Nr. 1223/2009 und zur Aufhebung der Richtlinien 90/385/EWG und 93/42/EWG des Rates. Insbesondere werden sie nicht verwendet für: Diagnose, Prävention, Überwachung, Vorhersage, Prognose, Behandlung oder Linderung von Krankheiten, Verletzungen oder Behinderungen, einschließlich der Entschädigung für Verletzungen oder Behinderungen.